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Department of Chemistry, Iowa State University, Ames, IowaABSTRACT The M2 protein of the influenza A virus acts both as a drug-sensitive proton channel and mediates virus budding
through membrane scission. The segment responsible for causing membrane curvature is an amphipathic helix in the cyto-
plasmic domain of the protein. Here, we use 31P and 13C solid-state NMR to examine M2-induced membrane curvature.
M2(22–46), which includes only the transmembrane (TM) helix, and M2(21–61), which contains an additional amphipathic helix,
are studied. 31P chemical shift lineshapes indicate that M2(21–61) causes a high-curvature isotropic phase to both cholesterol-
rich virus-mimetic membranes and 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayers, whereas M2(22–46) has minimal
effect. The lamellar and isotropic domains have distinct 31P isotropic chemical shifts, indicating perturbation of the lipid head-
group conformation by the amphipathic helix. 31P- and 13C-detected 1H T2 relaxation and two-dimensional peptide-lipid corre-
lation spectra show that M2(21–61) preferentially binds to the high-curvature domain. 31P linewidths indicate that the isotropic
vesicles induced by M2(21–61) are 10–35 nm in diameter, and the virus-mimetic vesicles are smaller than the 1,2-dimyristoyl-
sn-glycero-3-phosphocholine vesicles. A strong correlation is found between high membrane curvature and weak drug-binding
ability of the TM helix. Thus, the M2 amphipathic helix causes membrane curvature, which in turn perturbs the TM helix confor-
mation, abolishing drug binding. These NMR experiments are applicable to other curvature-inducing membrane proteins such as
fusion proteins and antimicrobial peptides.INTRODUCTIONMany membrane peptides and proteins cause curvature to
the phospholipid bilayer as their mechanism of action.
Examples include viral fusion proteins (1–3), antimicrobial
peptides (4–6), cell penetrating peptides (7), and proteins
that pinch off newly assembled viruses from host cells (8).
Protein-induced membrane curvature can be examined by
small-angle x-ray scattering (6,9) and electron microscopy
(EM) (10,11), which, however, cannot detect the protein
structure. Solid-state NMR spectroscopy is a unique tool
to simultaneously investigate membrane curvature and
the high-resolution structures of membrane proteins (12).
31P chemical shifts depend sensitively on the phase and
dynamics of the lipid membrane (13). Lamellar bilayers
with uniaxially mobile lipids give rise to static 31P powder
patterns with a motionally narrowed span of ~45 ppm,
with the maximum intensity at the low-frequency edge of
the powder pattern. Lipid morphologies with isotropic
symmetry, including micelles, small isotropic vesicles, and
cubic phases, manifest a narrow peak at the 31P isotropic
shift of ~0 ppm. The width of the isotropic peak depends
on the size of the isotropic domain: the smaller the
assembly, the faster the lipid reorientation over the surface
of the isotropic domain, and the sharper the 31P signal
(14). Hexagonal phases exhibit a powder pattern that is in-
verted from the lamellar phase powder pattern around the
isotropic shift, and the chemical shift span is halved (15).
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(20), and other membrane-active peptides (21,22). However,
few studies have investigated protein partitioning into
membrane domains with different curvatures. Knowledge
of protein partitioning is important, because membrane
protein conformation and dynamics can be sensitive to
membrane curvature, in addition to other environmental
factors (23).
The M2 protein of influenza A viruses have been exten-
sively studied for its drug-sensitive proton channel activity
(24,25). M2 assembles into a tetrameric bundle that opens
at low pH to conduct protons (26). Endocytosis of the virus
into the acidic endosome of the host cell opens the channel,
acidifies the virion, and releases the viral ribonucleoprotein
complex into the cell. The channel is inhibited by the ada-
mantane class of antiviral drugs. Mutagenesis and electro-
physiological experiments suggested the drug-binding site
to lie in the transmembrane (TM) pore (27–29). This is
supported by a high-resolution x-ray crystal structure (30)
of the M2 TM peptide (M2TM), which showed amantadine
(Amt) electron densities in the N-terminal pore. However,
a solution NMR structure of a longer M2 construct contain-
ing both the TM domain and an amphipathic cytoplasmic
helix did not detect drug in the pore, but instead found
drug-protein crosspeaks for residues on the C-terminal
lipid-facing surface of the TM helix (31). A subsequent
solid-state NMR study revealed that this surface site results
from nonspecific association of excess drugs from the
membrane, whereas the pore site near residue S31 is the
high-affinity binding site (32,33).doi: 10.1016/j.bpj.2012.01.010
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mediates membrane scission of the newly assembled virus
from the host cell (8). Electron and immunofluorescence
microscopy data showed that the wild-type protein causes
membrane curvature to large unilamellar vesicles, whereas
amphipathic helix mutants abolish this effect in vitro and
arrest virus budding in vivo (8). A peptide corresponding
to the amphipathic helix reproduced the membrane budding
effect of the full-length protein. The curvature-inducing
effect of M2 is moderated by cholesterol. In phase-separated
giant unilamellar vesicles composed of sphingomyelin
(SM), polyunsaturated phosphocholine, and cholesterol,
M2 resides at the boundary between the liquid-ordered
and liquid-disordered phases.
In this study, we use 31PNMR to characterize the curvature-
inducingeffect ofM2and 1H relaxationand 1H-31P correlation
NMR to determine the location of M2 in membrane domains
with different curvatures. We investigate the interactions of
M2(22–46) and M2(21–61) with 1,2-dimyristoyl-sn-glycero-
3-phosphocholine (DMPC) bilayers and with a cholesterol-
rich virus-envelope-mimetic membrane. Our data reveal the
effect of membrane curvature on the conformation and
drug-binding capability of the TM domain.FIGURE 1 Static 31P spectra of DMPC (a–c) and VM (d–i) membranes
in the absence and presence of M2 at 303 K. (a, d, and g) Protein-free
lipid bilayers. (b, e, and h) M2TM-containing membranes. (c, f, and i)
M2(21–61)-containing membranes. The DMPC spectra (a–c) and the VM
spectra (d–f) were measured on samples with Amt, whereas the VM spectra
(g, h, and i) were measured on samples without Amt.MATERIALS AND METHODS
Membrane sample preparation
M2(22–46) and M2(21–61) were synthesized using Fmoc chemistry by
PrimmBiotech (Cambridge, MA) and purified to >95% purity. M2(22–46)
spans only the TM domain, whereas M2(21–61) contains both the TM and
amphipathic helices. Both peptides were 13C, 15N-labeled at V27, S31,
G34, and D44.
DMPC bilayers and a mixed membrane (VM) mimicking the virus enve-
lope lipid composition were used to reconstitute the peptides. The VM
membrane is composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine,
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, egg SM with predomi-
nantly 16:0 acyl chains, and cholesterol at a mole ratio of 21:21:28:30%. The
lipids were codissolved in chloroform and methanol, dried under a stream of
nitrogen, redissolved in cyclohexane, and lyophilized to obtain a homoge-
neous dry powder. The powder was suspended in pH 7.5 phosphate buffer
(10 mM Na2HPO4/NaH2PO4, 1 mM EDTA, 0.1 mM NaN3) and freeze-
thawed six times to produce a uniform suspension. The peptides were
solubilized in octylglucoside solution and incubated with the lipid vesicle
solution at room temperature overnight, followed by dialysis for 3 days at
4C (34). 1H solution NMR spectra confirmed the quantitative removal of
octylglucoside from the membrane at the end of the dialysis (Table S1 in
the Supporting Material). No freeze-thawing was applied after dialysis, to
prevent formation of small isotropic vesicles unrelated to the effect of M2.
The proteoliposomes were centrifuged at 150,000  g for 4 h to give
membrane pellets with ~40 wt% hydration, which were packed into 4 mm
magic-angle-spinning (MAS) rotors forNMRexperiments. The peptide/lipid
molar ratio was 1:8 for M2(22–46) and 1:15 for M2(21–61), both of which
correspond to mass ratios of ~1:2. Many samples contain Amt at 5:1 drug/
tetramer mole ratio, which corresponds to 2.0–3.8% of the lipid mass (see
the Supporting Material), to monitor drug dynamics in separate studies (33).
As controls, peptide-free DMPC and VM lamellar membranes were
prepared by freeze-thawing the vesicle suspension three times for DMPC
and eight times for VM membranes. Small isotropic DMPC vesicles were
prepared by 10 cycles of freeze-thawing followed by 40 min of sonication.Biophysical Journal 102(4) 787–794Solid-state NMR experiments
NMR experiments were carried out on a Bruker DSX-400 MHz spectrom-
eter at 9.4 Tesla and an AVANCE 600 MHz spectrometer at 14.1 Tesla
using 4 mm MAS probes. Typical radiofrequency pulse lengths were 3.5–
5.0 ms for 1H and 5 ms for 31P and 13C. 13C chemical shifts were referenced
to the 13CO signal of a-Gly at 176.49 ppm on the tetramethylsilane scale,
and 31P chemical shifts were referenced to the 31P peak of hydroxyapatite
at 2.73 ppm.
One-dimensional static and MAS 31P spectra were measured at 298 or
303 K to distinguish lamellar bilayers from small isotropic vesicles. All
temperatures were measured by a thermocouple placed a few millimeters
from the MAS rotor. At the near-ambient temperature, moderate spinning
speeds and air flows used in our experiments, the temperature gradient over
the samples is small and the sample temperature is within 2C of the thermo-
couple reported value based on calibrations using 207Pb NMR of lead nitrate.
31P and 13C-detected 1HT2 decaysweremeasuredusing the pulse sequence in
Fig. S1 a at 298Kunder 7 kHzMAS.By comparing peptide 13C-detected and
lipid 31P-detected 1H T2 decays, we determine whether M2 is preferentially
bound to the lamellar or the isotropic domain. 31P-detected 1H T2 relaxation
decays of peptide-free controlmembranesweremeasured under 5 kHzMAS.
1H spin diffusion mixing times varied from 25 to 100 ms.
Two-dimensional (2D) 1H-31P and 1H-13C heteronuclear correlation
(HETCOR) spectra were measured at 14.1 Tesla at 297 K under 7.5 kHz
MAS. 1H homonuclear decoupling during the evolution period was
achieved using the FSLG sequence (35) (Fig. S1 b) with a transverse field
strength of 62.5 kHz. 1H chemical shift was calibrated using N-formyl-Met-
Leu-Phe-OH, whose 1H isotropic shifts are known (36). Lee-Goldburg
cross-polarization was used to suppress 1H spin diffusion. The cross-polar-
ization contact time was 3 ms for 1H-31P and 300 ms for 1H-13C HETCOR.
A mixing time of 300 ms was used after the t1 period to equilibrate the
peptide and lipid 1H magnetization.RESULTS
M2(21–61) causes high-curvature isotropic
membrane domains
To investigate the curvature-inducing effect of M2, we
measured the static 31P spectra of DMPC and VM mem-
branes without and with peptides (Fig. 1). All spectra
FIGURE 2 Static (black) and MAS (red) 31P spectra of lipid membranes
without and with M2. Inset expands the MAS spectra. (a) M2(21–61)-
DMPC membranes at 303 K. (b) DMPC isotropic vesicles at 298 K. (c)
M2TM-VM membranes at 303 K. (d) M2(21–61)-VM membrane at
303 K. An isotropic peak at about þ2 ppm is observed in a and d.
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shape, as expected for liquid-crystalline lamellar bilayers. In
addition, several samples exhibit a significant isotropic peak
near 0 ppm. All membranes containing M2(21–61) show
this isotropic peak (bottom row), whereas M2(22–46) does
not cause the isotropic peak to the VM membrane and
only a small isotropic peak to the DMPC membrane (middle
row). The isotropic linewidth varies from 6.0 ppm for the
M2(21–61)-DMPC sample to 2.2 ppm for the M2(21–61)-
VM sample. For control samples without the peptide (top
row), the DMPC bilayer does not show any isotropic peak,
consistent with the absence of intrinsic curvature strain of
phosphocholine, whereas the VM membrane shows a strong
isotropic peak when Amt is present (see Fig. 1 d) but a weak
one when the drug is absent (see Fig. 1 g).
A narrow isotropic peak in static 31P spectra indicates the
presence of lipids that undergo fast isotropic reorientation
on the NMR timescale. This motion can be tumbling of
small vesicles in solution, or lateral diffusion of lipids
over the highly curved membrane domain. The isotropic
phase can be small vesicles, cubic phases, or even micelles.
Given the hydration level of ~40% for our samples, fast
tumbling is unlikely, thus we attribute the isotropic peak
primarily to lipid lateral diffusion. Regardless of the mech-
anism of line narrowing, the isotropic peak indicates the
presence of a high-curvature membrane domain with
isotropic symmetry, distinct from the lamellar phase.
Both M2(21–61) and the drug induce the isotropic phase.
In the absence of M2 and Amt, the DMPC and VM
membranes exhibit no or very little isotropic peak. However,
when Amt is present, the VM membrane shows a strong
isotropic peak while DMPC does not (Fig. 1, a and d).
Thus, Amt and cholesterol synergistically exert curvature
strain to the membrane. Cholesterol is known to be inserted
into the glycerol and acyl chain regions of the lipid bilayer
(37), thus the curvature strain is negative, as indicated by
x-ray diffraction, EM, and NMR studies of various choles-
terol-containing membranes (38–40). Solid-state NMR
data and molecular dynamics simulations indicate that
Amt also partitions to the glycerol region of the membrane
(41), thus it should enhance the negative curvature. The fact
that M2(22–46) completely suppressed this isotropic phase
in the VM membrane (Fig. 1, e and h), indicates that it
counters the action of Amt and cholesterol by inducing
positive curvature. Independent of the effect of the drug,
M2(21–61) causes membrane curvature, as shown by the
drug-free VM spectrum containing the peptide (Fig. 1 i).
Although 31P anisotropic shift indicates the phase and
morphology of the membrane, isotropic 31P chemical shift
measured under MAS indicates the chemical environment
and headgroup conformation of the lipids. Fig. 2 superim-
poses the static and MAS spectra of DMPC and VM
membranes with and without M2. For the M2(21–61)-
DMPC sample, the MAS spectrum resolved two isotropic
peaks (Fig. 2 a): the þ1.9 ppm peak matches the isotropicpeak in the static spectrum, whereas the 1.1 ppm peak
matches the average of the three principal values of the
lamellar powder pattern reported recently (32). The
different isotropic shifts indicate that the isotropic lipids
adopt a different headgroup conformation from the lamellar
lipids, suggesting peptide perturbation. The isotropic
shift difference is not caused by membrane curvature,
because a peptide-free DMPC small vesicle sample showed
a 1.0 ppm isotropic shift (Fig. 2 b), identical to the
isotropic shift of the lamellar lipids.
For the M2TM-VM sample free of the isotropic phase
(Fig. 2 c), 31P isotropic shifts of 0.90 and 0.32 ppm
are observed that can be attributed to lamellar 1,2-dipalmi-
toyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glyc-
ero-3-phosphoethanolamine, and SM lipids. In comparison,
the M2(21–61)-VM sample has an additional isotropic peak
at þ1.8 ppm (Fig. 2 d), in good agreement with the þ2.1
ppm isotropic peak in the static spectrum. Thus, for both
DMPC and VM membranes, the high-curvature phase
caused by M2(21–61) exhibit 31P isotropic shifts that are
2–3 ppm larger than the isotropic shift of the lamellar lipids.31P and 13C detected 1H T2 relaxation
The resolution of the 31P isotropic shifts between the high-
curvature domain and the lamellar domain allows us to
use high-sensitivity MAS experiments to determine M2
partitioning. The peptide-enriched domain should exhibit
similar 1H relaxation properties between peptide 13C detec-
tion and lipid 31P detection. The peptide-rich domain has
stronger 1H-1H dipolar couplings and thus should exhibit
faster 1H T2 decay than the lipid-rich domain. LipidBiophysical Journal 102(4) 787–794
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further relaxation differences (see below). In the experi-
ment, no 1H homonuclear decoupling is applied during the
spin-echo period (Fig. S1 a), to maximize the relaxation
difference between the more rigid, peptide-rich, domain,
and the more mobile, peptide-poor, domain. A moderate
spin diffusion time is applied to equilibrate the 1H magneti-
zation within each domain.
Fig. 3 compares the 31P and 13C-detected 1H T2 relaxation
decays for three membrane samples. The M2(21–61)-
DMPC sample (Fig. 3 a) has both isotropic and lamellar
phases. The 1H T2 decay detected from the 1.1 ppm
lamellar 31P signal is slower than the decay of the isotropic
lipid peak at þ1.9 ppm: at an echo delay of 4 ms, the
lamellar signal decayed to 66% while the isotropic signal
decayed to 31%. The peptide 13C-detected 1H T2 relaxation
superimposes almost completely with the T2 decay of the
high-curvature lipid domain. Thus, M2(21–61) partitions
preferentially into the high-curvature phase, experiencing
the same 1H dynamics as the isotropic lipids. All 1H T2
decays are double exponential, with decay constants of 0.3
and 14 ms (15% and 85%) for the lamellar lipids and 0.12
and 6 ms (40% and 60%) for the isotropic lipids (Table
S2). The initial fast decay is most likely due to the rigid
peptide protons. The faster relaxation of the isotropic lipids
is a result of both a higher percentage of the initial decay and
the shorter relaxation time of the slow component. The
13C-detected curves gave 1H T2 values of 0.2 and 6.1 ms,
in quantitative agreement with the isotropic lipid data. The
T2 values are largely independent of the spin diffusion mix-
ing time between 25 and 225 ms (Table S2), indicating that
at 25 ms, the 1H T2-values already report the average prop-
erty of the lipids, protein, and water at equilibrium.
Fig. 3 b shows the 1H T2 decays of the M2TM-VM
membrane, which does not exhibit an isotropic phase andFIGURE 3 31P- and 13C-detected 1H T2 relaxation of M2-containing membra
lipids. Green: 31P-detected 1H T2 decay of isotropic lipids. Blue:
13C-detected 1H
Ca. (a) M2(21–61)-DMPC membranes with 1H spin diffusion times of 25 ms
0.37 ppm lamellar 31P peak. Open circles: 1.0 ppm lamellar 31P peak. 1H s
61)-VM membranes with a 25 ms 1H spin diffusion mixing time.
Biophysical Journal 102(4) 787–794the peptide must therefore bind entirely to the lamellar
phase. The 13C-detected 1H T2 decays exhibit time constants
of 0.2 ms (45%) and 3 ms (55%), similar to the 13C data of
the M2(21–61)-DMPC sample. However, the two lamellar
31P signals now decay much faster than the lamellar signal
in the M2(21–61)-DMPC sample: the decay constants are
0.45 ms (60%) and 3.5 ms (40%). Thus, the 13C and 31P-de-
tected 1H T2 decays are similar in this purely lamellar
membrane, verifying the ability of this indirectly detected
1H T2 experiment to report the dynamic environment of
the protein and lipids. The two 31P isotropic peaks of this
mixed membrane have the same 1H T2 decays, confirming
that 1H T2 relaxation is influenced by curvature-dependent
lipid motion rather than by the chemical structure of the
lipid headgroup.
Fig. 3 c shows the 1H T2 relaxation of the M2(21–61)-VM
sample. The 31P MAS spectrum resolves two lamellar
peaks at 0.37 and 1.0 ppm and an isotropic-lipid peak
at þ1.8 ppm (Fig. 2 d). Similar to the DMPC sample, the
lamellar lipids show slower T2 relaxation than the isotropic
lipids. The 13C-detected T2 relaxation is even faster than that
of the isotropic lipids, indicating that M2(21–61) preferen-
tially binds to the high-curvature membrane domain.
To examine the effect of the peptide on the 31P-detected
1H relaxation of the lipids, we compared the T2 decays of
membranes without and with M2 (Fig. 4). For the DMPC
membrane, peptide-free isotropic lipids have similar relax-
ation as peptide-bound isotropic lipids (Fig. 4 a). In
comparison, peptide-free lamellar lipids have slower T2
decay than peptide-containing lamellar lipids, indicating
that the presence of M2 in the lamellar phase speeds up
relaxation due to the rigid protons. The VM membrane
shows the same trend: the lamellar lipids have longer T2
relaxation times in the absence of M2 than in its presence
(Fig. 4, b and c).nes at 298 K under 7 kHz MAS. Red: 31P-detected 1H T2 decay of lamellar
T2 decay of the peptide. Solid triangles: S31 Ca/Cb. Open triangles: G34
for 31P and 49 ms for 13C. (b) M2(22–46)-VM membranes. Solid circles:
pin diffusion mixing times: 100 ms for 31P and 25 ms for 13C. (c) M2(21–
FIGURE 4 31P-detected 1H T2 relaxation decays without (black) and with (red and green) M2 at 298 K. (a) DMPC bilayers with and without M2(21–61).
(b) VM membranes with and without M2(22–46). (c) VM membranes with and without M2(21–61).
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The indirectly detected 1H T2 relaxation experiment probes
the location of the peptide by comparing the dynamic envi-
ronment of the lipids and the peptide. To determine peptide-
lipid contact directly, we measured 2D 1H-31P and 1H-13C
HETCOR spectra. We look for 31P crosspeaks with peptide
amide protons, which resonate in the 5–10 ppm range, well
separated from the lipid and water 1H signals. Fig. 5, a and
b, shows the 2D 1H-13C HETCOR spectra of M2(21–61) in
DMPC bilayers without and with 1H spin diffusion. Ca
crosspeaks with HN at ~8 ppm are observed even without
spin diffusion and are enhanced with a 200 ms 1H spin diffu-
sion period (Fig. 5, d and e). In the 1H-31P HETCOR spec-
trum, the same HN chemical shift shows a crosspeak with
the high-curvature lipid signal (þ1.9 ppm) but not with
the lamellar signal (1.1 ppm) (Fig. 5, c, f, and g), even
though the latter is five times higher than the isotropicFIGURE 5 1H-13C and 1H-31P 2D HETCOR spectra of M2(2161)-DMPC
The S31 Ca/Cb 1H cross section is shown in d. (b) 1H-13C HETCOR spectrum
1H-31P HETCOR spectrum with 250 ms 1H spin diffusion and 3 ms Lee-Goldb
are shown in f and g, respectively. All spectra were measured at 297 K with 1Hpeak. This proves unambiguously that M2(21–61) preferen-
tially binds the high-curvature membrane domain.
In the VM membrane, M2(21–61) also shows an HN
crosspeak with the isotropic lipid (Fig. S2). However, the
sphingosine backbone of SM also contains an amide proton,
which gives rise to an HN-P crosspeak even in the absence of
the peptide. Thus, the HN crosspeak with the þ1.8 ppm 31P
signal cannot be definitively assigned to M2, unless SM can
be ascertained to be excluded from the isotropic domain.DISCUSSION
Electron and fluorescence microscopy data showed that M2
plays important roles in influenza virus filament formation,
virus budding, and release (8,10,42). The common under-
lying mechanism for these functions is the ability of the
protein to cause membrane curvature, which occurs inmembranes. (a) 1H-13C HETCOR spectrum without 1H spin diffusion.
with 200 ms 1H spin diffusion. The S31 cross section is shown in e. (c)
urg cross-polarization. The 1H cross sections at þ1.9 ppm and 1.1 ppm
homonuclear decoupling under 7.5 kHz MAS.
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792 Wang et al.a cholesterol-dependent manner (8). However, molecular
details of this curvature induction and M2-cholesterol inter-
action are still scarce. The current 31P, 1H, and 13C NMR
data, detecting membrane morphology and peptide-lipid
interactions on the 1–50 nm length scale, provide useful
insight into the relationship between M2 structure and
membrane curvature generation. The static 31P NMR line-
shapes show unequivocally that M2(21–61) causes an
isotropic phase while M2(22–46) does not, and the curva-
ture is higher for the cholesterol-rich VM membrane than
for the DMPC membrane. The isotropic phase can in prin-
ciple be small vesicles, cubic phases, or even micelles,
and EM or x-ray diffraction experiments would be required
to determine the morphology definitively. However, a large
body of literature on cholesterol-containing membranes
suggests that the cubic phase is much less likely than small
vesicles under our experimental conditions. Cubic phases in
phosphocholine and cholesterol-containing membranes are
mostly found for polyunsaturated lipids (39,40) under very
high hydration and temperature (~60C above the phase
transition temperature), whereas our VM membranes
contain saturated lipids at ~40% hydration and experiments
were conducted at moderate temperatures of 297–303 K.
Cubic phases are usually observed in association with the
inverse hexagonal phase (40), which is absent in our
samples (43). Various cationic membrane peptides incur
cubic phases when the membrane contains a high level of
negative-curvature phosphatidylethanolamine lipids (6,7),
but the VM membrane contains equimolar phosphatidyleth-
anolamine and phosphatidylcholine lipids. Therefore, the
high-curvature phase caused by M2(21–61) most likely
corresponds to small isotropic vesicles or isotropic domains
in the lamellar phase. These isotropic lipids are not
completely separated from the lamellar lipids, because 2D
31P-31P correlation spectra show crosspeaks between the
lamellar and isotropic peaks within 50 ms (Fig. S4). A
partial association of the isotropic phase with the lamellar
phase is consistent with EM images showing M2-containing
small vesicles budding off of large unilamellar vesicles (8).
A similar example of protein-induced membrane budding is
reported for the myelin basic protein, which also causes an
isotropic peak in the 31P NMR spectra, and whose cryoelec-
tron microscopy images show small daughter vesicles
pinching off of large parent vesicles (44).
Whereas the 31P spectra reveal the presence of an
isotropic phase, 1H T2 relaxation and HETCOR experiments
show that M2(21–61) is preferentially bound to the high-
curvature domain. The 1H T2 relaxation rates are influenced
by both the membrane curvature and the presence of rigid
protein protons. In the lamellar domain, the main lipid
motions are trans-gauche isomerization and uniaxial diffu-
sion. Both motions significantly average the 1H-1H dipolar
couplings under MAS (45), making it inefficient for driving
T2 relaxation. As a result lamellar lipids show relatively
slow 1H T2 relaxation under MAS. In the isotropic phase,Biophysical Journal 102(4) 787–794an additional reorientational motion, lateral diffusion over
the surface of the isotropic domain, is present. This motion
has a much longer rotational correlation time (tL). Based
on a lateral diffusion coefficient DL of 3–10  108 cm2/s,
which spans the values reported for a wide range of
membrane compositions (46–49), tL¼ r2/6 DL is 2–6 ms
for a vesicle diameter of ~10 nm. Such microsecond motion
is much more efficient in driving T2 relaxation, thus causing
faster T2 decays even in the absence of the peptide (Fig. 4 a).
In addition to the lipid dynamic difference, the rigidity of
the peptide also speeds up 1H T2 relaxation and likely
accounts for the fast initial decay in the M2-containing
samples. Indeed, peptide-free control membranes show
a much smaller fraction of the initial decay (Fig. 4).
Curvature induction and peptide partitioning are coupled,
as they should, because M2(21–61) cannot continue to
create the high-curvature lipid phase while remaining in
the lamellar phase without depleting the latter completely.
31P spectral integration (Figs. 1 and 2) indicates that the
isotropic domain accounts for 10–20% of the total lipids.
Because the peptide/lipid mass ratio in the samples is
~1:2, if we assume a conservative upper limit of 20% for
lamellar-phase M2 that is undetected by our experiments,
then the peptide should represent at least 67 wt% of the
isotropic domain, which suggests that each M2(21–61)
tetramer would be solvated by ~14 lipid molecules. This
high peptide density should significantly perturb lipid
packing, thus explaining the 3-ppm 31P isotropic shift differ-
ence between the isotropic and the lamellar lipids.
Assuming that the isotropic domain corresponds to small
vesicles, we can estimate the vesicle size or radius of
curvature using the static 31P linewidths. The higher the
curvature, the narrower the isotropic peak. 31P spectral
simulation as a function of vesicle diameter has been re-
ported where motional narrowing by both vesicle tumbling
and lipid lateral diffusion was considered (14). We modify
that analysis to exclude vesicle tumbling due to the
moderate hydration of our samples, and consider only
lateral diffusion. Using a DL range of 3–10  108 cm2/s
to span the literature values for both protein-containing
and protein-free membranes of varying viscosity, we find
a mean diameter of ~26 nm for the isotropic DMPC vesicles,
which has a 6-ppm linewidth for the isotropic peak, and
a diameter of ~10 nm for the VM vesicles, which have a
2.2-ppm linewidth (see the Supporting Material). Future
experiments using dynamic light scattering and electron
microscopy will be useful to verify these size estimates.
Fig. 6 depicts the different curvatures of the three types of
M2-containing membranes. Isolated vesicles are assumed in
these models, but the trend also applies to intralamellar
isotropic domains. M2TM causes no or little curvature
to DMPC and VM membranes (Fig. 6 a), both of which
support drug binding based on previous peptide-drug dis-
tance measurements and 2D correlation spectra (33,50).
Thus, formation of drug-sensitive tetrameric TM channels
FIGURE 6 Models of the effects of M2 peptides on membrane curvature.
(a) M2TM does not cause curvature to the VM membrane and adopts
a conformation competent to bind drug (blue triangle) in the lamellar
bilayer. (b) M2(21–61) causes strong curvature to the VM membrane and
binds the resulting small unilamellar vesicles, in which it adopts a confor-
mation incompetent to bind drug. (c) M2(21–61) causes moderate curvature
to DMPC bilayers, and the TM helix conformation is partially able to bind
drug.
Protein Binding to Curved Membrane Domains 793requires low membrane curvature. In contrast, M2(21–61)
causes strong curvature to the VM membrane (Fig. 6 b),
in which it does not bind drug at all (32), and moderate
curvature to the DMPC membrane (Fig. 6 c), in which it
partially binds drug. The estimated 10 nm diameter for the
isotropic VM vesicles is about the minimum size of small
unilamellar vesicles (51,52) before entering the realm of
ultrasmall unilamellar vesicles (5–10 nm diameter) and
micelles, whereas the 26-nm DMPC isotropic vesicle would
correspond to two bilayers separated by a water layer. These
results suggest that the high curvature of the small vesicles
perturb the TM helix packing, thus abolishing drug binding.
In the smallest unilamellar vesicles, the amphipathic helix
(53) likely resides on the outer surface, with the N-terminus
of the TM domain facing the vesicle interior, which should
further reduce drug binding (Fig. 6 b).
The strong correlation between high membrane curvature
and weak drug binding also suggests the reason for the
absence of pore-bound drug in the 1,2-dihexanoyl-sn-glyc-
ero-3-phosphocholine-micelle solubilized M2(18–60) (31).
The aggregation number of 1,2-dihexanoyl-sn-glycero-3-
phosphocholine is 84, which gives a micelle diameter that
is about twofold smaller than the 10-nm isotropic VM vesi-
cles. In this highly curved micelle, the conformation of the
TM pore should be even more perturbed than in small
bilayer vesicles, thus preventing drug binding.
The curvature of the VM membrane is caused by the
combined action of the amphipathic helix and cholesterol:
the removal of either, by using DMPC lipids or by using
M2TM, moderates or suppresses the curvature. Wild-typeM2 has been shown to bind cholesterol (10,54), possibly
between residues 47 and 55 of the amphipathic helix. In
real virus envelopes and host plasma membranes, where
the lipid distribution is spatially heterogeneous and tempo-
rally dynamic and where other viral proteins exist, M2 is
thought to cluster at the boundary between the raft and non-
raft domains in the former but associated with the nonraft
domain in the latter (8,54). Either environment has lower
cholesterol levels, thus the membrane curvature should be
more moderate than observed here in the synthetic lipid
mixtures, which would shift the protein conformation equi-
librium toward the drug-bound state.SUPPORTING MATERIAL
Estimation of isotropic vesicle sizes from 31P NMR linewidths, M2 and
amantadine contents of the various lipid membranes, four figures, two
tables, and references are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(12)00066-5.
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